Business and Industry Press

July 17, 2011
The Wall Street Journal
Alzheimer’s Treatment Showcase Is Set
 Click here to read article

July 15, 2011
BioMedReports.com
News Makers: Also Friday... News in the healthcare sector on July 15, 2011.
 Click here to read article

July 7, 2011
Pharmaceutical Business Review
Clinical Trials News: Anavex starts 30mg dose step in Alzheimer’s drug Phase 1 trial
 Click here to read article

July 6, 2011
Benzinga.com
Anavex rapidly advances ANAVEX 2-73 for Alzheimer’s disease, Phase I clinical trial progressing well
 Click here to read article

July 6, 2011
BioMedReports.com
News Makers: Anavex Starts Phase I Clinical Trial To Evaluate ANAVEX 2-73
 Click here to read article

May 2, 2011
Pharmaceutical Business Review
First-In-Human Dosing Commenced in Alzheimer’s Trial
 Click here to read article

April 1, 2011
Pharmaceutical Business Review
Clinical Trials News: Anavex screens first subject in Alzheimer’s drug trial
 Click here to read article

March 21, 2011
Drug Discovery & Development
Anavex Granted Alzheimer’s Trial Approval
 Click here to read article

March 20 - March 27, 2011
Alzheimer’s Weekly
Anavex Trial to be Initiated Immediately in Germany
 Click here to read article

March 16, 2011
International Business Times
Germans to Receive First Dose of Anavex Life Sciences’ (AVXL) Alzheimer Drug
 Click here to read article

March 10, 2011, page 14
Pharmaceutical Executive Global Digest
Appointments: Dr. Paul Aisen
 Click here to read article

January 2, 2011
About.com Biotech/Biomedical Blog
Theresa’s Biotech/Biomedical Blog: Top Small Biotech Companies of 2010
 Click here to read article

December 26, 2010 - January 2, 2011
Alzheimer’s Weekly
2010 Trial-of-the-Year: Anavex Enters Phase I
 Click here to read article

September 14, 2010
Pharmaceutical Business Review
Anavex Life Sciences publishes ANAVEX 2-73 data
 Click here to read article

July/August 2010, page 18
PharmaVOICE Magazine
The PharmaVOICE 100
Dr. Cameron Durrant: Grounded in Excellence
 Click here to read article

March 31, 2010
Applied Clinical Trials Blog
Chasing After Amyloid
 Click here to read article

Media/Experts Directory

July 23, 2010
Sources (Media Directory)
Sources welcomes Dr. Cameron Durrant, MD, MBA, Alzheimer’s disease and
Pharmaceuticals/Biotech Expert
 Click here to read Sources’ announcement
 Click here to read Dr. Durrant’s profile

Radio Interview


March 26, 2010
Business @ Night on CFRA AM News Talk Radio (Ottawa, Ontario)
In a two-part interview, Business @ Night Host Greg Hebert speaks with Dr. Cameron Durrant, Executive Chairman of Anavex Life Sciences, about the company’s upcoming clinical trials and its compelling drug candidate for the treatment and modification of Alzheimer’s disease.

Listen to:
 Part 1 of Dr. Durrant’s interview (click here)
 Part 2 of Dr. Durrant’s interview (click here)